Orlistat
CAS 96829-58-2 11 FDA-DMF suppliersSmall Molecule
Overview
Orlistat is a drug designed to treat obesity by inhibiting the absorption of dietary fats. It works by blocking the enzyme lipase, which is necessary for the digestion of fats.
API suppliers (7)
Suppliers of Orlistat backed by a verifiable FDA Type II Drug Master File. Source: FDA quarterly DMF list.
- CHONGQING CARELIFE PHARMACEUTICAL CO LTDChina1 active DMF
- Forest Laboratories, Inc.United States1 active DMF
- CHONGQING CARELIFE PHARMACEUTICAL CO LTDChina1 active DMF
- Biocon LimitedIndia1 active DMF
- Forest Laboratories, Inc.United States1 active DMF
- CHONGQING CARELIFE PHARMACEUTICAL CO LTDChina1 active DMF
- Zhejiang Hisun Pharmaceutical Co., Ltd.China
Chemical identity
- IUPAC name
- [(2S)-1-[(2S,3S)-3-hexyl-4-oxooxetan-2-yl]tridecan-2-yl] (2S)-2-formamido-4-methylpentanoate
- Canonical SMILES
- CCCCCCCCCCC[C@@H](C[C@H]1[C@@H](C(=O)O1)CCCCCC)OC(=O)[C@H](CC(C)C)NC=O
- InChIKey
- AHLBNYSZXLDEJQ-FWEHEUNISA-N
Therapeutic areas
Obesity
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.